TSS
TNDM icon

Two Sigma Securities’s Tandem Diabetes Care TNDM Stock Holding History

Two Sigma Securities’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34,572
Closed -$1.47M – 3624
2024
Q2 		$1.39M Buy
+34,572
New +$1.44M 0.02% 902
2023
Q4 		– Sell
-32,765
Closed -$680K – 3592
2023
Q3 		$681K Buy
+32,765
New +$900K 0.01% 1295
2022
Q4 		– Sell
-5,168
Closed -$234K – 3260
2022
Q3 		$247K Buy
+5,168
New +$283K 0.01% 1747
2022
Q1 		– Sell
-1,603
Closed -$241K – 2512
2021
Q4 		$241K Buy
+1,603
New +$216K 0.01% 949
2021
Q2 		– Sell
-3,177
Closed -$280K – 1709
2021
Q1 		$280K Sell
3,177
-850
-21% -$79K 0.02% 464
2020
Q4 		$385K Buy
+4,027
New +$415K 0.01% 857
2020
Q1 		– Sell
-3,468
Closed -$207K – 2292
2019
Q4 		$207K Buy
+3,468
New +$214K ﹤0.01% 2075
2017
Q4 		– Sell
-3,754
Closed -$27K – 2001
2017
Q3 		$27K Buy
+3,754
New +$23.8K ﹤0.01% 803

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's TNDM Position: Q3 2024 in Review

Two Sigma Securities sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 34,572 shares — an estimated $1.47M sold.

Two Sigma Securities first reported a position in TNDM in Q3 2017 and held it in 8 quarters. The position peaked at $1.39M in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Two Sigma Securities reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 34,572 Tandem Diabetes Care shares in Q3 2024, an estimated $1.47M.
  • Two Sigma Securities first reported a position in Tandem Diabetes Care in Q3 2017 and held it in 8 quarters.
  • Two Sigma Securities's Tandem Diabetes Care position peaked at $1.39M in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.